{"id":"ad503110-4c16-42ff-9c74-2b378937a470","kind":"companies","code":"UB-C11503","name":"Hexagon Bio","nameBasis":"source-english","summary":"Fungal-genomics-driven oncology and infectious-disease drug discovery company","description":"Company Leadership Board of Directors Clinical Advisory Board Scientific Advisory Board Technical Advisory Board Investors Partners Pipeline Technology Overview Antibody-Drug Conjugate (ADC) Platform Publications News Press Releases In the News Careers Open Positions Novel ADC Pa","country":"United States","category":null,"originalName":"Hexagon Bio","eventDate":null,"website":"https://hexagonbio.com/","sourceUpdatedAt":"2026-10-25T00:00:00.000Z","englishUpdatedAt":"2026-11-01T02:29:42.392Z","reviewedAt":"2026-11-01T02:29:42.392Z","snapshotAt":"2026-11-01T00:40:31.077Z","sourceHash":"ffd901f9fff25f165d6ead9d335395f6d9b8a8c504b635b2fc176b818fa00bef","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"真菌基因组学驱动的肿瘤与传染病药物发现公司\n\nCompany Leadership Board of Directors Clinical Advisory Board Scientific Advisory Board Technical Advisory Board Investors Partners Pipeline Technology Overview Antibody-Drug Conjugate (ADC) Platform Publications News Press Releases In the News Careers Open Positions Novel ADC Pa","sources":[],"related":[{"id":"3ca70087-3025-4894-afad-947a85f9117a","kind":"news","code":"3ca70087-3025-4894-afad-947a85f9117a","name":"Hexagon Bio raises $62 million Series C","nameBasis":"translated-title","summary":"On 2026-10-23, according to fireround, Hexagon Bio raises $62 million in Series C funding.","description":"","country":null,"category":null,"originalName":"Hexagon Bio 完成 $62 million C轮 融资","eventDate":"2026-10-23T00:00:00.000Z","website":"https://www.globenewswire.com/news-release/2026/10/23/3387153/0/en/hexagon-bio-raises-62-million-series-c-financing-to-advance-hex-360-into-the-clinic-and-expand-pipeline-of-antibody-drug-conjugates-with-novel-payload-mechanisms.html","sourceUpdatedAt":"2026-10-26T03:24:19.833Z","englishUpdatedAt":"2026-10-26T12:00:40.341Z","reviewedAt":"2026-10-26T12:00:40.341Z","snapshotAt":"2026-10-26T11:53:09.349Z","sourceHash":"68a7b82adbf370599a40dfc7341a994840c3a7eb48749bd68ac263519864f88f","companyId":"ad503110-4c16-42ff-9c74-2b378937a470","foundedYear":null,"logoUrl":null,"transactionConsiderationUsd":null,"considerationLabel":null,"amountEstimateUsd":62000000,"fundingEstimateUsd":62,"fundingEstimateLabel":"$62","path":"/news/3ca70087-3025-4894-afad-947a85f9117a"},{"id":"a3295212-00c6-4e6b-b2d4-d339272f9bdb","kind":"institutions","code":"UB-I3541","name":"The Column Group","nameBasis":"original-brand","summary":"The Column Group is a life sciences venture capital firm.","description":"The Column Group is a life sciences venture capital firm.","country":"United States","category":null,"originalName":"The Column Group","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-31T12:00:22.825Z","englishUpdatedAt":"2026-11-01T01:51:56.888Z","reviewedAt":"2026-11-01T01:51:56.888Z","snapshotAt":"2026-11-01T00:42:29.102Z","sourceHash":"35fed7f5675af4bc0826a6124f557028fa20a5a8fd9866b9ae78a7678e994055","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/the-column-group"}],"finance":{"funding":{"metric":"funding","count":1,"latest":{"value":62,"text":"$62 million","date":"2026-10-23T00:00:00.000Z","round":"Series C","estimate":"$62","considerationUsd":null,"considerationLabel":null},"years":[2026],"points":[{"year":2026,"date":"2026-10-23T00:00:00.000Z","round":"Series C","value":62,"eventIds":["3ca70087-3025-4894-afad-947a85f9117a"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[{"id":"3ca70087-3025-4894-afad-947a85f9117a","date":"2026-10-23T00:00:00.000Z","round":"Series C","amountText":"$62 million","estimateUsd":62,"estimateLabel":"$62","estimateNote":null,"considerationUsd":null,"considerationLabel":null,"investors":null,"institutions":[{"id":"a3295212-00c6-4e6b-b2d4-d339272f9bdb","kind":"institutions","code":"UB-I3541","name":"The Column Group","nameBasis":"original-brand","summary":"The Column Group is a life sciences venture capital firm.","description":"The Column Group is a life sciences venture capital firm.","country":"United States","category":null,"originalName":"The Column Group","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-31T12:00:22.825Z","englishUpdatedAt":"2026-11-01T01:51:56.888Z","reviewedAt":"2026-11-01T01:51:56.888Z","snapshotAt":"2026-11-01T00:42:29.102Z","sourceHash":"35fed7f5675af4bc0826a6124f557028fa20a5a8fd9866b9ae78a7678e994055","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/the-column-group"}],"newsUrl":"https://www.globenewswire.com/news-release/2026/10/23/3387153/0/en/hexagon-bio-raises-62-million-series-c-financing-to-advance-hex-360-into-the-clinic-and-expand-pipeline-of-antibody-drug-conjugates-with-novel-payload-mechanisms.html","evidence":{"headline":"Hexagon Bio raises $62 million Series C","brief":"On 2026-10-23, according to fireround, Hexagon Bio raises $62 million in Series C funding.","basis":"translated-source-brief","newsPath":"/news/3ca70087-3025-4894-afad-947a85f9117a","sourceCount":1}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"3ca70087-3025-4894-afad-947a85f9117a","date":"2026-10-23T00:00:00.000Z","round":"Series C","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"considerationUsd":null,"considerationLabel":null,"investors":null,"institutions":[{"id":"a3295212-00c6-4e6b-b2d4-d339272f9bdb","kind":"institutions","code":"UB-I3541","name":"The Column Group","nameBasis":"original-brand","summary":"The Column Group is a life sciences venture capital firm.","description":"The Column Group is a life sciences venture capital firm.","country":"United States","category":null,"originalName":"The Column Group","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-31T12:00:22.825Z","englishUpdatedAt":"2026-11-01T01:51:56.888Z","reviewedAt":"2026-11-01T01:51:56.888Z","snapshotAt":"2026-11-01T00:42:29.102Z","sourceHash":"35fed7f5675af4bc0826a6124f557028fa20a5a8fd9866b9ae78a7678e994055","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/the-column-group"}],"newsUrl":"https://www.globenewswire.com/news-release/2026/10/23/3387153/0/en/hexagon-bio-raises-62-million-series-c-financing-to-advance-hex-360-into-the-clinic-and-expand-pipeline-of-antibody-drug-conjugates-with-novel-payload-mechanisms.html","evidence":{"headline":"Hexagon Bio raises $62 million Series C","brief":"On 2026-10-23, according to fireround, Hexagon Bio raises $62 million in Series C funding.","basis":"translated-source-brief","newsPath":"/news/3ca70087-3025-4894-afad-947a85f9117a","sourceCount":1}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"3ca70087-3025-4894-afad-947a85f9117a","kind":"funding","eventDate":"2026-10-23T00:00:00.000Z","revenueDate":null,"round":"C轮","amountText":"$62 million","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":62,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"transactionConsiderationUsd":null,"considerationLabel":null,"investors":null,"newsUrl":"https://www.globenewswire.com/news-release/2026/10/23/3387153/0/en/hexagon-bio-raises-62-million-series-c-financing-to-advance-hex-360-into-the-clinic-and-expand-pipeline-of-antibody-drug-conjugates-with-novel-payload-mechanisms.html","newsTypes":["融资"],"institutions":[{"id":"a3295212-00c6-4e6b-b2d4-d339272f9bdb","kind":"institutions","code":"UB-I3541","name":"The Column Group","nameBasis":"original-brand","summary":"The Column Group is a life sciences venture capital firm.","description":"The Column Group is a life sciences venture capital firm.","country":"United States","category":null,"originalName":"The Column Group","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-31T12:00:22.825Z","englishUpdatedAt":"2026-11-01T01:51:56.888Z","reviewedAt":"2026-11-01T01:51:56.888Z","snapshotAt":"2026-11-01T00:42:29.102Z","sourceHash":"35fed7f5675af4bc0826a6124f557028fa20a5a8fd9866b9ae78a7678e994055","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/the-column-group"}],"roundName":"Series C","amountLabel":"$62","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[],"productsRelated":[],"investors":[{"id":"a3295212-00c6-4e6b-b2d4-d339272f9bdb","kind":"institutions","code":"UB-I3541","name":"The Column Group","nameBasis":"original-brand","summary":"The Column Group is a life sciences venture capital firm.","description":"The Column Group is a life sciences venture capital firm.","country":"United States","category":null,"originalName":"The Column Group","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-31T12:00:22.825Z","englishUpdatedAt":"2026-11-01T01:51:56.888Z","reviewedAt":"2026-11-01T01:51:56.888Z","snapshotAt":"2026-11-01T00:42:29.102Z","sourceHash":"35fed7f5675af4bc0826a6124f557028fa20a5a8fd9866b9ae78a7678e994055","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/the-column-group"}],"path":"/companies/hexagon-bio","structured":{"city":null,"country":"United States","location":null,"role":null,"category":null,"company":null},"definition":"Hexagon Bio is a company headquartered in United States.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/companies/hexagon-bio"}